Real-time enrollment status for this acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 10:23 AM UTC
| NCT Number | NCT03630991 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia |
| Phase | PHASE1 |
| Target Enrollment | 58 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | August 25, 2026 (1 week ago) |
As of September 2, 2026: Clinical trial NCT03630991 is currently recruiting participants. This phase1 study for acute myeloid leukemia is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03630991 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03630991 was last updated 1 week ago (August 25, 2026). HelloStudys verifies this status automatically.